GSK’s ViiV Healthcare and its bimonthly pre-exposure prophylaxis (PrEP) medicine Apretude had to make room for another ...
Trials should assess overall survival to evaluate potential harm, with crossover limited to avoid confounding treatment ...
Researchers from Johns Hopkins University and the University of Colorado conducted a double-blinded, placebo controlled crossover study which found that limonene, a commonly occurring terpene in ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apnimed, a clinical-stage pharmaceutical company focused on developing oral pharmacologic treatments to address obstructive sleep apnea (OSA) and related disorders, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results